Sennoside B


CAS No. : 128-57-4

128-57-4
Price and Availability of CAS No. : 128-57-4
Size Price Stock
10mg $25 In-stock
25mg $50 In-stock
50mg $80 In-stock
100 mg Get quote
200 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-N0366
M.Wt: 862.74
Formula: C42H38O20
Purity: >98 %
Solubility: DMSO : 100 mg/mL (ultrasonic)
Introduction of 128-57-4 :

Sennoside B is a potent and orally active platelet-derived growth factor (PDGF) inhibitor. Sennoside B inhibits cell proliferation and the expression of phosphorylation of PDGFR-β, STAT-5, AKT and ERK induced by PDGF-BB. Sennoside B shows gastroprotective activities. Sennoside B has the potential for the research of gastritis[1][2]. In Vitro:Sennoside B increases prostaglandin E2 (PGE2) levels and inhibits H+/K+-ATPase[1].
Sennoside B (50, 100 µM) increases the concentration of PGE2 to 105.4 pg/mL and 173.6 pg/mL in AGS gastric cells at doses of 50 μM and 100 μM, respectively[1].
Sennoside B (0, 10, 100, 1000 nM) decreases the expression of PDGF-BB-induced phosphorylation of PDGFR-β, STAT-5, AKT and ERK in a dose-dependent manner[2]. In Vivo:Sennoside B (100 mg/kg; p.o.) shows gastroprotective activities by reducing lesion indices in HCl•EtOH and Indomethacin (HY-14397) induces gastritis in rats[1].

Your information is safe with us.